InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Cheaper Medicines Act signed into law


On June 6 2008, the president of the Philippines signed into law Republic Act no 9052 entitled Universally Accessible Cheaper and Quality Medicine Act of 2008. The director-general of the Intellectual Property Office and other appropriate government agencies are mandated to issue the implementing rules and regulations of the Act within 120 days. Republic Act no 9052 contains a number of important points.

First, it amends the IP Code to state as non-patentable the mere discovery of a new form of a new property of a known substance which does not result in the enhancement of the known efficacy of that substance, or the mere discovery of any...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

.@EuropeanCommiss EU - Latin America survey on IPRs, internationalisation & SMEs http://t.co/u6XVOBZqPz

Jul 1 2015 04:31 ·  reply ·  retweet ·  favourite
ManagingIP profile

How automotive industry is putting the brakes on NPEs with PTAB petitions & defensive patent aggregators http://t.co/an6Z5ePu8l ($/trial)

Jul 1 2015 03:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

Happy Birthday to James Nurton our Managing Editor! http://t.co/QOYw7KQNEz

Jul 1 2015 02:25 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements